{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:28:58Z","timestamp":1786422538940,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07293-8","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:04:47Z","timestamp":1785809087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["JAK inhibitor therapy in CANDLE syndrome: a systematic review of clinical outcomes in 46 patients"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4736-6803","authenticated-orcid":false,"given":"Seyed Mohammad","family":"Vahabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4069-7289","authenticated-orcid":false,"given":"Elnaz","family":"Pourgholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8776-6604","authenticated-orcid":false,"given":"Can Berk","family":"Leblebici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1767-9809","authenticated-orcid":false,"given":"William J.","family":"Crisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2683-3750","authenticated-orcid":false,"given":"Sama","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-3975","authenticated-orcid":false,"given":"Joe K.","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"3","key":"7293_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaad.2009.04.046","volume":"62","author":"A Torrelo","year":"2010","unstructured":"Torrelo A, Patel S, Colmenero I, Gurbindo D, Lend\u00ednez F, Hern\u00e1ndez A et al (2010) Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome. J Am Acad Dermatol 62(3):489\u2013495","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"7293_CR2","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1172\/JCI81260","volume":"125","author":"A Brehm","year":"2015","unstructured":"Brehm A, Liu Y, Sheikh A, Marrero B, Omoyinmi E, Zhou Q et al (2015) Additive loss-of-function proteasome subunit mutations in CANDLE\/PRAAS patients promote type I IFN production. J Clin Investig 125(11):4196\u20134211","journal-title":"J Clin Investig"},{"issue":"3","key":"7293_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clindermatol.2023.07.003","volume":"41","author":"MC Koska","year":"2023","unstructured":"Koska MC, Karada\u011f AS, Durdu M (2023) Annular neutrophilic dermatoses. Clin Dermatol 41(3):340\u2013354","journal-title":"Clin Dermatol"},{"key":"7293_CR4","doi-asserted-by":"crossref","unstructured":"Caps T, Hids F, Blau C (2013) Autoinflammatory diseases in dermatology. Autoinflammatory Disorders, an Issue of Dermatologic Clinics 31(3):387\u2013404","DOI":"10.1016\/j.det.2013.04.005"},{"issue":"6","key":"7293_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/DAD.0000000000002345","volume":"45","author":"A Altom","year":"2023","unstructured":"Altom A, Khader SAE, Gad AG, Anadani R, Dang DP, Ansar F et al (2023) Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature syndrome: a systemic review. Am J Dermatopathol 45(6):355\u2013370","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"7293_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5114\/polp.2024.142557","volume":"99","author":"A Snopkowska","year":"2024","unstructured":"Snopkowska A, Go\u0142da J, M\u0119\u017cyk J, Gacka P, Do\u0142\u0119ga M (2024) CANDLE syndrome \u2013 a narrative review. Pediatr Pol 99(4):335\u2013339. https:\/\/doi.org\/10.5114\/polp.2024.142557","journal-title":"Pediatr Pol"},{"key":"7293_CR7","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900447","author":"WJ Crisler","year":"2019","unstructured":"Crisler WJ, Eshleman EM, Lenz LL (2019) Ligand-induced IFNGR1 down-regulation calibrates myeloid cell IFN\u03b3 responsiveness. Life Sci Alliance. https:\/\/doi.org\/10.26508\/lsa.201900447","journal-title":"Life Sci Alliance"},{"issue":"21","key":"7293_CR8","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL, Wang Y, Cheon H, Kanno Y, Gadina M, Sartorelli V et al (2022) The JAK-STAT pathway at 30: Much learned, much more to do. Cell 185(21):3857\u20133876","journal-title":"Cell"},{"issue":"1","key":"7293_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"7293_CR10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaci.2021.08.004","volume":"148","author":"Y Luo","year":"2021","unstructured":"Luo Y, Alexander M, Gadina M, O\u2019Shea JJ, Meylan F, Schwartz DM (2021) JAK-STAT signaling in human disease: from genetic syndromes to clinical inhibition. Journal of Allergy and Clinical Immunology 148(4):911\u2013925","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"7293_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.abd.2023.03.001","volume":"98","author":"HA Miot","year":"2023","unstructured":"Miot HA, Criado PR, Castro C, Ianhez M, Talhari C, Ramos PM (2023) JAK-STAT pathway inhibitors in dermatology. An Bras Dermatol 98(5):656\u201377","journal-title":"An Bras Dermatol"},{"key":"7293_CR12","doi-asserted-by":"crossref","unstructured":"Liu M, Gao Y, Yuan Y, Yang K, Shen C, Wang J, Tian J (2023) Janus kinase inhibitors for alopecia areata: a systematic review and meta-analysis. JAMA Network Open 6(6):e2320351-e","DOI":"10.1001\/jamanetworkopen.2023.20351"},{"issue":"1","key":"7293_CR13","first-page":"14","volume":"18","author":"R Sedano","year":"2022","unstructured":"Sedano R, Ma C, Jairath V, Feagan BG (2022) Janus kinase inhibitors for the management of patients with inflammatory bowel disease. Gastroenterology & hepatology 18(1):14","journal-title":"Gastroenterol Hepatol"},{"issue":"4","key":"7293_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/jpm11040279","volume":"11","author":"H-R Tsai","year":"2021","unstructured":"Tsai H-R, Lu J-W, Chen L-Y, Chen T-L (2021) Application of Janus kinase inhibitors in atopic dermatitis: an updated systematic review and meta-analysis of clinical trials. Journal of Personalized Medicine 11(4):279","journal-title":"J Personalized Med"},{"issue":"3","key":"7293_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jaad.2025.05.1377","volume":"93","author":"MS Ansari","year":"2025","unstructured":"Ansari MS, Vahabi SM, Memari H, Hosseini F, Bahramian S, Etesami I (2025) Use of the oral Janus kinase inhibitor tofacitinib in the treatment of morphea: a retrospective study. J Am Acad Dermatol 93(3):769\u2013771","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"7293_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.70101","volume":"7","author":"P Fazeli","year":"2025","unstructured":"Fazeli P, Bahramian S, Farahmand K, Ghoshouni H, Farahmand Y, Soheili A et al (2025) JAK inhibitors for treatment of SAPHO syndrome: a systematic review of 72 cases. ACR Open Rheumatol 7(10):e70101","journal-title":"ACR Open Rheumatol"},{"key":"7293_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.70150","author":"SM Vahabi","year":"2026","unstructured":"Vahabi SM, Heidari S, Pourgholi E, Memari H, Hashemnejad MA, Ansari MS et al (2026) Janus kinase inhibitors for the treatment of prurigo nodularis: a systematic review of 211 patients. J Dermatol. https:\/\/doi.org\/10.1111\/1346-8138.70150","journal-title":"J Dermatol"},{"issue":"1","key":"7293_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/drp\/9127126","volume":"2025","author":"S Bahramian","year":"2025","unstructured":"Bahramian S, Fazeli P, Rafati A, Demokri S, Memari H, Soheili A et al (2025) JAK inhibitors for treatment of VEXAS syndrome: a systematic review of 186 cases. Dermatol Res Pract 2025(1):9127126","journal-title":"Dermatol Res Pract"},{"issue":"4","key":"7293_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.72301","volume":"9","author":"MS Ansari","year":"2026","unstructured":"Ansari MS, Heidari S, Pourgholi E, Bahramian S, Tootoonchi N, Vahabi SM (2026) Janus kinase inhibitors for treatment of palmoplantar pustulosis, generalized pustular psoriasis, and palmoplantar pustular psoriasis: a systematic review of the literature. Health Science Reports 9(4):e72301","journal-title":"Health Sci Rep"},{"key":"7293_CR20","doi-asserted-by":"publisher","first-page":"7086209","DOI":"10.1155\/drp\/7086209","volume":"2026","author":"SM Vahabi","year":"2026","unstructured":"Vahabi SM, Heidari S, Farahmand Y, Pourgholi E, Kianfar N, Memari H et al (2026) JAK inhibitors for treatment of pyoderma gangrenosum and sweet syndrome: a systematic review of published case reports. Dermatol Res Pract 2026:7086209","journal-title":"Dermatol Res Pract"},{"key":"7293_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","volume":"134","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2020) Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol 134:103\u2013112","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"7293_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12969-023-00817-8","volume":"21","author":"N Kanazawa","year":"2023","unstructured":"Kanazawa N, Ishii T, Takita Y, Nishikawa A, Nishikomori R (2023) Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS\/CANDLE, SAVI, and AGS). Pediatr Rheumatol Online J 21(1):38","journal-title":"Pediatr Rheumatol Online J"},{"issue":"7","key":"7293_CR23","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/JCI98814","volume":"128","author":"GAM Sanchez","year":"2018","unstructured":"Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y et al (2018) JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest 128(7):3041\u20133052","journal-title":"J Clin Invest"},{"issue":"6","key":"7293_CR24","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/pde.15667","volume":"41","author":"W Guo","year":"2024","unstructured":"Guo W, Lozeau D, Tonnesen M, Schuval S, de Jesus A, Miller D et al (2024) A case of mother and child with CANDLE syndrome: diagnosis and subsequent treatment with baricitinib. Pediatr Dermatol 41(6):1162\u20135","journal-title":"Pediatr Dermatol"},{"key":"7293_CR25","doi-asserted-by":"publisher","first-page":"1190104","DOI":"10.3389\/fimmu.2023.1190104","volume":"14","author":"JJ Papendorf","year":"2023","unstructured":"Papendorf JJ, Ebstein F, Alehashemi S, Piotto DGP, Kozlova A, Terreri MT et al (2023) Identification of eight novel proteasome variants in five unrelated cases of proteasome-associated autoinflammatory syndromes (PRAAS). Front Immunol 14:1190104","journal-title":"Front Immunol"},{"issue":"3","key":"7293_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/annrheumdis-2021-221486","volume":"81","author":"A Remy","year":"2022","unstructured":"Remy A, Borocco C, Sarrabay G, Boursier G, Fraitag S, Catteau B et al (2022) When extended genetics rescues diagnosis: a patient with CANDLE-like phenotype and de novo mutation in the SAMD9L gene. Ann Rheum Dis 81(3):447\u2013448","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7293_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/pde.14517","volume":"38","author":"PN Patel","year":"2021","unstructured":"Patel PN, Hunt R, Pettigrew ZJ, Shirley JB, Vogel TP, de Guzman MM (2021) Successful treatment of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome with tofacitinib. Pediatr Dermatol 38(2):528\u20139","journal-title":"Pediatr Dermatol"},{"issue":"20","key":"7293_CR28","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.3390\/ijms21207767","volume":"21","author":"A Pin","year":"2020","unstructured":"Pin A, Tesser A, Pastore S, Moressa V, Valencic E, Arbo A et al (2020) Biological and clinical changes in a pediatric series treated with off-label JAK inhibitors. Int J Mol Sci 21(20):7767","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7293_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12969-019-0322-9","volume":"17","author":"M Boyadzhiev","year":"2019","unstructured":"Boyadzhiev M, Marinov L, Boyadzhiev V, Iotova V, Aksentijevich I, Hambleton S (2019) Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome. Pediatr Rheumatol Online J 17(1):19","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"7293_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jaad.2018.08.043","volume":"80","author":"MA Cardis","year":"2019","unstructured":"Cardis MA, Montealegre Sanchez GA, Goldbach-Mansky R, Richard Lee CC, Cowen EW (2019) Recurrent fevers, progressive lipodystrophy, and annular plaques in a child. J Am Acad Dermatol 80(1):291\u2013295","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"7293_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/acr.23506","volume":"70","author":"D Buchbinder","year":"2018","unstructured":"Buchbinder D, Sanchez GAM, Goldbach-Mansky R, Brunner H, Shulman AI (2018) Rash, fever, and pulmonary hypertension in a 6-year-old female. Arthritis Care & Research 70(5):785","journal-title":"Arthritis Care Res"},{"key":"7293_CR32","first-page":"44","volume":"72","author":"S Torreggiani","year":"2020","unstructured":"Torreggiani S, Pillet P, De Oliveira PF, Kozlova A, Shcherbina A, De Guzman M et al (2020) Clinical features and outcomes in chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome: before and after JAK-inhibition. Arthritis and Rheumatology 72:44\u201347","journal-title":"Arthritis Rheumatol"},{"key":"7293_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/annrheumdis-2023-eular.4573","volume":"82","author":"Y Levinsky","year":"2023","unstructured":"Levinsky Y, Scheuerman O, Tal R, Amarilyo G, Harel L (2023) POS0754 proteasome activity test as a potential clinical tool for the diagnosis of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome and related proteasome disorders. Ann Rheum Dis 82:668","journal-title":"Ann Rheum Dis"},{"key":"7293_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12969-023-00879-8","volume":"21","author":"S Ringold","year":"2023","unstructured":"Ringold S, Tomlinson G, Schanberg L, Del Gaizo V, Murphy K, Feldman B, Ong M, Natter M, Kimura Y (2023) Rheumatology Congress. Pediatr Rheumatol Online J 21:122","journal-title":"Pediatr Rheumatol Online J"},{"key":"7293_CR35","doi-asserted-by":"crossref","unstructured":"Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018). Pediatr Rheumatol 16 (Suppl 2), 52 (2018). https:\/\/doi.org\/10.1186\/s12969-018-0265-6","DOI":"10.1186\/s12969-018-0265-6"},{"issue":"3","key":"7293_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s10875-018-0485-z","volume":"38","author":"MM Pereira","year":"2018","unstructured":"Pereira MM, Brown A, Vogel T (2018) A case of CANDLE syndrome. J Clin Immunol 38(3):330","journal-title":"J Clin Immunol"},{"key":"7293_CR37","doi-asserted-by":"crossref","unstructured":"Rosa M. Alcobendas SML, Pablo F. Fraga, Clara U (2019) Gascon, Catarina Fervenza, Agustin Remesal. P1046 Vasculitis in autoinflammatory diseases in a tertiary hospital - 10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID). Pediatr Rheumatol 17(1):18","DOI":"10.1186\/s12969-019-0313-x"},{"key":"7293_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/637629","author":"AV Gomes","year":"2013","unstructured":"Gomes AV (2013) Genetics of proteasome diseases. Scientifica (Cairo). https:\/\/doi.org\/10.1155\/2013\/637629","journal-title":"Scientifica (Cairo)"},{"issue":"15","key":"7293_CR39","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s00018-012-0938-0","volume":"69","author":"F Ebstein","year":"2012","unstructured":"Ebstein F, Kloetzel P-M, Kr\u00fcger E, Seifert U (2012) Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Cell Mol Life Sci 69(15):2543\u20132558","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"7293_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2332\/allergolint.11-RAI-0416","volume":"61","author":"N Kanazawa","year":"2012","unstructured":"Kanazawa N (2012) Nakajo-Nishimura syndrome: an autoinflammatory disorder showing pernio-like rashes and progressive partial lipodystrophy. Allergol Int 61(2):197\u2013206","journal-title":"Allergol Int"},{"issue":"6","key":"7293_CR41","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/pde.12984","volume":"33","author":"G Xirotagaros","year":"2016","unstructured":"Xirotagaros G, Hern\u00e1ndez\u2010Ostiz S, Ar\u00f3stegui JI, Torrelo A (2016) Newly described autoinflammatory diseases in pediatric dermatology. Pediatr Dermatol 33(6):602\u201314","journal-title":"Pediatr Dermatol"},{"key":"7293_CR42","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3389\/fimmu.2017.00927","volume":"8","author":"A Torrelo","year":"2017","unstructured":"Torrelo A (2017) CANDLE syndrome as a paradigm of proteasome-related autoinflammation. Front Immunol 8:927","journal-title":"Front Immunol"},{"issue":"2","key":"7293_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/ijd.12695","volume":"54","author":"A McDermott","year":"2015","unstructured":"McDermott A, Jacks J, Kessler M, Emanuel PD, Gao L (2015) Proteasome\u2010associated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management. Int J Dermatol 54(2):121\u2013129","journal-title":"Int J Dermatol"},{"issue":"3","key":"7293_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.det.2013.04.005","volume":"31","author":"SV Tripathi","year":"2013","unstructured":"Tripathi SV, Leslie KS (2013) Autoinflammatory diseases in dermatology: CAPS, TRAPS, HIDS, FMF, Blau, CANDLE. Dermatol Clin 31(3):387\u2013404","journal-title":"Dermatol Clin"},{"key":"7293_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.930071","volume":"9","author":"Z Boyadzhieva","year":"2022","unstructured":"Boyadzhieva Z, Ruffer N, Burmester G, Pankow A, Krusche M (2022) Effectiveness and safety of JAK inhibitors in autoinflammatory diseases: a systematic review. Front Med 9:930071","journal-title":"Front Med"},{"issue":"3","key":"7293_CR46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/art.33368","volume":"64","author":"Y Liu","year":"2012","unstructured":"Liu Y, Ramot Y, Torrelo A, Paller AS, Si N, Babay S et al (2012) Mutations in proteasome subunit \u03b2 type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheum 64(3):895\u2013907","journal-title":"Arthritis Rheum"},{"key":"7293_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.717388","volume":"12","author":"J Hadjadj","year":"2021","unstructured":"Hadjadj J, Fr\u00e9mond M-L, Neven B (2021) Emerging place of JAK inhibitors in the treatment of inborn errors of immunity. Front Immunol 12:717388","journal-title":"Front Immunol"},{"issue":"1","key":"7293_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12519-019-00273-z","volume":"16","author":"Z-X Yu","year":"2020","unstructured":"Yu Z-X, Song H-M (2020) Toward a better understanding of type I interferonopathies: a brief summary, update and beyond. World Journal of Pediatrics 16(1):44\u201351","journal-title":"World J Pediatr"},{"issue":"9","key":"7293_CR49","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/ard-2023-225463","volume":"83","author":"KC Gedik","year":"2024","unstructured":"Gedik KC, Ortega-Villa AM, Materne G, Rastegar A, Sanchez GAM, Reinhardt A et al (2024) Disease flares with baricitinib dose reductions and development of flare criteria in patients with CANDLE\/PRAAS. Ann Rheum Dis 83(9):1181\u20131188","journal-title":"Ann Rheum Dis"},{"key":"7293_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2025.06.003","author":"J Moreau","year":"2025","unstructured":"Moreau J, Chikhoune L, Poggi C, Stabler S, Letarouilly J-G, Hachulla \u00c9, Launay D (2025) Safety profile of JAK inhibitors in inflammatory or autoimmune diseases. Rev Med Interne. https:\/\/doi.org\/10.1016\/j.revmed.2025.06.003","journal-title":"Rev Med Interne"},{"issue":"5","key":"7293_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050861","volume":"16","author":"SM Vahabi","year":"2024","unstructured":"Vahabi SM, Bahramian S, Esmaeili F, Danaei B, Kalantari Y, Fazeli P et al (2024) JAK inhibitors in cutaneous T-cell lymphoma: friend or foe? A systematic review of the published literature. Cancers (Basel) 16(5):861","journal-title":"Cancers (Basel)"},{"issue":"1","key":"7293_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/14728214.2024.2445508","volume":"30","author":"D Politano","year":"2025","unstructured":"Politano D, Tonduti D, Battini R, Fazzi E, Orcesi S (2025) Exploring emerging JAK inhibitors in the treatment of Aicardi\u2013Gouti\u00e8res syndrome. Expert Opin Emerg Drugs 30(1):21\u201339","journal-title":"Expert Opin Emerg Drugs"},{"key":"7293_CR53","doi-asserted-by":"crossref","unstructured":"Rajput Khokhar A, Ghoreschi K, Huynh J (2025) Adverse effects of Janus kinase inhibitors with relevance for daily practice in dermatology. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 23(9):1127\u201340","DOI":"10.1111\/ddg.15796"},{"key":"7293_CR54","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.70122","author":"D Isufi","year":"2025","unstructured":"Isufi D, Javanmardi N, Jensen MB, Loft N, Skov L, Elberling J et al (2025) Risk of dyslipidemia associated with oral Janus kinase inhibitors: a systematic review and meta\u2010analysis of randomized placebo\u2010controlled trials. Int J Dermatol. https:\/\/doi.org\/10.1111\/ijd.70122","journal-title":"Int J Dermatol"},{"key":"7293_CR55","doi-asserted-by":"crossref","unstructured":"Gedik KC, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, Adang LA, Armangue T, Barchus K, Cordova DR, Crow YJ (2022) The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI and AGS. Ann Rheum Dis 81(5):601\u2013613","DOI":"10.1136\/annrheumdis-2021-221814"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07293-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07293-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07293-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:49:29Z","timestamp":1786420169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07293-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7293"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07293-8","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI tools were used to assist with language editing and paraphrasing. These tools did not generate original scientific content, influence data analysis or interpretation, or determine study conclusions. All intellectual input, methodological decisions, and final responsibility for the manuscript rest solely with the authors.","order":4,"name":"Ethics","label":"Declaration of AI","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"637"}}